Your browser doesn't support javascript.
loading
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.
Rampling, Tommy; Ewer, Katie J; Bowyer, Georgina; Bliss, Carly M; Edwards, Nick J; Wright, Danny; Payne, Ruth O; Venkatraman, Navin; de Barra, Eoghan; Snudden, Claudia M; Poulton, Ian D; de Graaf, Hans; Sukhtankar, Priya; Roberts, Rachel; Ivinson, Karen; Weltzin, Rich; Rajkumar, Bebi-Yassin; Wille-Reece, Ulrike; Lee, Cynthia K; Ockenhouse, Christian F; Sinden, Robert E; Gerry, Stephen; Lawrie, Alison M; Vekemans, Johan; Morelle, Danielle; Lievens, Marc; Ballou, Ripley W; Cooke, Graham S; Faust, Saul N; Gilbert, Sarah; Hill, Adrian V S.
Afiliación
  • Rampling T; The Jenner Institute.
  • Ewer KJ; The Jenner Institute.
  • Bowyer G; The Jenner Institute.
  • Bliss CM; The Jenner Institute.
  • Edwards NJ; The Jenner Institute.
  • Wright D; The Jenner Institute.
  • Payne RO; The Jenner Institute.
  • Venkatraman N; The Jenner Institute.
  • de Barra E; Royal College of Surgeons in Ireland, Dublin.
  • Snudden CM; The Jenner Institute.
  • Poulton ID; The Jenner Institute.
  • de Graaf H; NIHR Wellcome Trust Clinical Research Facility, University of Southampton and University Hospital Southampton NHS Foundation Trust, United Kingdom.
  • Sukhtankar P; NIHR Wellcome Trust Clinical Research Facility, University of Southampton and University Hospital Southampton NHS Foundation Trust, United Kingdom.
  • Roberts R; The Jenner Institute.
  • Ivinson K; PATH Malaria Vaccine Initiative, Seattle, Washington.
  • Weltzin R; PATH Malaria Vaccine Initiative, Seattle, Washington.
  • Rajkumar BY; PATH Malaria Vaccine Initiative, Seattle, Washington.
  • Wille-Reece U; PATH Malaria Vaccine Initiative, Seattle, Washington.
  • Lee CK; PATH Malaria Vaccine Initiative, Seattle, Washington.
  • Ockenhouse CF; PATH Malaria Vaccine Initiative, Seattle, Washington.
  • Sinden RE; Department of Life Sciences.
  • Gerry S; Centre for Statistics in Medicine, University of Oxford.
  • Lawrie AM; The Jenner Institute.
  • Vekemans J; GSK Vaccines, Rixensart, Belgium.
  • Morelle D; GSK Vaccines, Rixensart, Belgium.
  • Lievens M; GSK Vaccines, Rixensart, Belgium.
  • Ballou RW; GSK Vaccines, Rixensart, Belgium.
  • Cooke GS; Infectious Diseases Section, Faculty of Medicine, Department of Medicine, Imperial College London.
  • Faust SN; NIHR Wellcome Trust Clinical Research Facility, University of Southampton and University Hospital Southampton NHS Foundation Trust, United Kingdom.
  • Gilbert S; The Jenner Institute.
  • Hill AV; The Jenner Institute.
J Infect Dis ; 214(5): 772-81, 2016 Sep 01.
Article en En | MEDLINE | ID: mdl-27307573
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Proteínas Protozoarias / Esquemas de Inmunización / Malaria Falciparum / Vacunas contra la Malaria Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Dis Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Proteínas Protozoarias / Esquemas de Inmunización / Malaria Falciparum / Vacunas contra la Malaria Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Dis Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos